We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Newly Developed Drug Demonstrates Potent, Selective Activity Against Trypanosomatid Parasites

By LabMedica International staff writers
Posted on 06 Apr 2016
Print article
Image: A small library of abietane-type diterpenoids amides was prepared from the plant-based dehydroabietylamine (left (1)) as a starting material, and the compounds evaluated for activity against Leishmania donovani and Trypanosoma cruzi. One compound (right (10)), an amide built from dehydroabietylamine and acrylic acid, was found to be highly effective against both parasites (Photo courtesy of Pirttimaa M et al., 2016, Journal of Natural Products).
Image: A small library of abietane-type diterpenoids amides was prepared from the plant-based dehydroabietylamine (left (1)) as a starting material, and the compounds evaluated for activity against Leishmania donovani and Trypanosoma cruzi. One compound (right (10)), an amide built from dehydroabietylamine and acrylic acid, was found to be highly effective against both parasites (Photo courtesy of Pirttimaa M et al., 2016, Journal of Natural Products).
Using a plant-based compound, scientists have developed a semi-synthetic drug that, upon testing on infected mammalian cells in culture, showed highly effective activity against two parasites from the trypanosomatid family: Leishmania donovani, a cause of visceral leishmaniasis, and Trypanosoma cruzi, cause of Chagas disease.

There are significant drawbacks for currently available therapeutic drugs for both diseases, indicating an urgent need for more effective and safer drugs. Plant- or marine-derived natural compounds are promising sources. For example, the abietane-type diterpenoids (AtDs) present in plants exhibit a wide range of biological activities including anti-inflammatory, antibacterial, antifungal, and antimalarial properties. A few AtDs have shown promising activity against parasites in the trypanosomatid family.

In the new study, an international team led by researchers at VTT Technical Research Centre of Finland Ltd. (Espoo, Finland) prepared a small library of AtD amides, using commercially available dehydroabietylamine (C-1) as a starting material, and evaluated activity of the new compounds against L. donovani and T. cruzi. Other researchers in the collaboration were from University of Helsinki (Helsinki, Finland), Hebrew University-Hadassah Medical School (Jerusalem, Israel), and Swiss Tropical and Public Health Institute (Basel, Switzerland).

From the library screening, the compound C-10, an amide built from dehydroabietylamine and acrylic acid, was found to be highly potent against both parasites. Against L. donovani axenic amastigotes, C-10 displayed an IC50=0.37 μM and an outstanding selectivity index (SI)=63. SI values of 20 or higher are considered “hit activity criteria for protozoa” when screening for new bioactive compounds. Moreover, C-10 fully inhibited the growth of intracellular L. donovani amastigotes in human macrophages (from monocyte cell line THP-1), with IC50=0.06 μM. C-10 was also highly effective against T. cruzi amastigotes in rat myoblast L6 cells (IC50=0.6 μM; SI=58), being 3.5 times more potent than the reference compound benznidazole. Cytotoxicity of C-10 for macrophages and rat myoblast L6 cells was also tested and found to be relatively low.

C-10 was one of only two library compounds that possess physicochemical properties allowing them to efficiently cross the cell membranes and effectively kill parasites residing inside the host cells, reflecting their potential to act at the relevant stages responsible for disease. Interestingly, C-10 showed 6-fold more potent activity against L. donovani in infected macrophages than against axenic amastigotes.

Overall, the work highlights C-10 as an important compound for further investigation and development in pursuit of better drugs for patients suffering from leishmaniasis and Chagas disease.

The study, by Pirttimaa M et al., was published on February 26, 2016, in ACS’s Journal of Natural Products.

Related Links:

VTT Technical Research Centre of Finland Ltd.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.